» Articles » PMID: 12556524

The Three Insulin Response Sequences in the Glucose-6-phosphatase Catalytic Subunit Gene Promoter Are Functionally Distinct

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Jan 31
PMID 12556524
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose-6-phosphatase catalyzes the terminal step in the gluconeogenic and glycogenolytic pathways. In HepG2 cells, the maximum repression of basal glucose-6-phosphatase catalytic subunit (G6Pase) gene transcription by insulin requires two distinct promoter regions, designated A (located between -231 and -199) and B (located between -198 and -159), that together form an insulin response unit. Region A binds hepatocyte nuclear factor-1, which acts as an accessory factor to enhance the effect of insulin, mediated through region B, on G6Pase gene transcription. We have previously shown that region B binds the transcriptional activator FKHR (FOXO1a) in vitro. Chromatin immunoprecipitation assays demonstrate that FKHR also binds the G6Pase promoter in situ and that insulin inhibits this binding. Region B contains three insulin response sequences (IRSs), designated IRS 1, 2, and 3, that share the core sequence T(G/A)TTTT. However, detailed analyses reveal that these three G6Pase IRSs are functionally distinct. Thus, FKHR binds IRS 1 with high affinity and IRS 2 with low affinity but it does not bind IRS 3. Moreover, in the context of the G6Pase promoter, IRS 1 and 2, but not IRS 3, are required for the insulin response. Surprisingly, IRS 3, as well as IRS 1 and IRS 2, can each confer an inhibitory effect of insulin on the expression of a heterologous fusion gene, indicating that, in this context, a transcription factor other than FKHR, or its orthologs, can also mediate an insulin response through the T(G/A)TTTT motif.

Citing Articles

Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke.

Li F, Gao J, Kohls W, Geng X, Ding Y Brain Circ. 2022; 8(2):69-75.

PMID: 35909706 PMC: 9336590. DOI: 10.4103/bc.bc_27_22.


A novel amino acid signaling process governs glucose-6-phosphatase transcription.

Fukushima S, Nishi H, Kumano M, Yamanaka D, Kataoka N, Hakuno F iScience. 2021; 24(7):102778.

PMID: 34278273 PMC: 8267547. DOI: 10.1016/j.isci.2021.102778.


Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex.

Sen S, Sanyal S, Srivastava D, Dasgupta D, Roy S, Das C J Biol Chem. 2017; 292(50):20362-20378.

PMID: 29042441 PMC: 5733577. DOI: 10.1074/jbc.M117.786863.


SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.

Cao J, Yu Y, Zhang Z, Chen X, Hu Z, Tong Q Diabetes. 2017; 67(1):46-57.

PMID: 28851713 PMC: 5741142. DOI: 10.2337/db17-0546.


Crystal structures reveal a new and novel FoxO1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter.

Singh P, Han E, Endrizzi J, OBrien R, Chi Y J Struct Biol. 2017; 198(1):54-64.

PMID: 28223045 PMC: 5443350. DOI: 10.1016/j.jsb.2017.02.006.